Biosimilars are coming: ready or not-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biosimilars are coming: ready or not

Published:2018-09 Issue:9 Volume:48 Page:1027-1034
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Zalcberg John¹^ORCID

Affiliation:

1. Cancer Research Program, School of Public Health and Preventive Medicine; Monash University; Melbourne Victoria Australia

Funder

Pfizer

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.14033/fullpdf

Reference36 articles.

1. Rituximab in the treatment of non-Hodgkin's lymphoma--a critical evaluation of randomized controlled trials;Griffin;Expert Opin Biol Ther,2013

2. IMS Institute for Healthcare Informatics http://www.quotidianosanita.it/allegati/allegato1501906.pdf

3. IMS Institute for Healthcare Informatics https://morningconsult.com/wp-content/uploads/2016/04/IMS-Institute-US-Drug-Spending-2015.pdf

4. European Medicines Agency http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/01/WC500180219.pdf

5. Patent expiry dates for biologicals: 2017 update;GaBI Journal Editor;GaBI J,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus-Based Overarching Principles and Recommendations on the Use of Biosimilars in the Treatment of Inflammatory Arthritis in the Gulf Region;BioDrugs;2024-02-25

2. Physicochemical and Functional Characterization of Medicinal Product Rinsulin® R;Drug development & registration;2023-05-28

3. Perceptions towards biologic and biosimilar therapy of patients with rheumatic and gastroenterological conditions;BMC Rheumatology;2022-12-23

4. A Checklist for Pharmacists on Biologics and Biosimilars;Biologics, Biosimilars, and Biobetters;2020-12-30

5. A consensus statement on the use of biosimilar medicines in hematology in Australia;Asia-Pacific Journal of Clinical Oncology;2020-04-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3